Keywords: ligand, request, nasdaq, de-listing, hearing, drugmaker, received

Ligand to request Nasdaq de-listing hearing

Article | 04 April 2005

Print This

US drugmaker Ligand has received notification of possible de-listing from the USA's Nasdaq stock market, following its failure to file ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in